Send EmailDana Van GorderExecutive Director
As Executive Director, Dana oversees Project Inform’s programmatic goals of assisting in the development of treatments for HIV and hepatitis C, providing treatment information to individuals and providers, engaging in advocacy to meet the health care needs of low-income people, and advocating for bio-medical prevention strategies.
- As 2012 comes to a close, consider a year-end gift to Project Inform!
- President Obama provides emergency HIV care and treatment funding
- PI Applauds Positive FDA PrEP Decision: Urges Immediate Implementation Steps
- Project Inform urges FDA to approve use of HIV medication for prevention
- Project Inform Lauds California HIV Research Program’s PrEP and TLC+ Studies
Send EmailAnne DonnellyDirector of Health Care Policy
Anne heavily influences the implementation of the Affordable Care Act through her advocacy work at the California state and national levels, as it relates to supporting the needs of people living with HIV and hepatitis C.
- WEBINAR: Integrating Community-Based Organizations and New Health Care Reform Health Homes
- ‘Covered California’ announces insurance plans and rates for 2014
- Revving up for Health Care Reform
- ACTION ALERT: Fight cuts to life-saving HIV services!
- Insurance company backs down on mail order pharmacy demand, at least for now
Send EmailDavid EvansDirector of Research Advocacy
David follows bio-medical and implementation science related to HIV cure, bio-medical prevention, and enhanced treatment options for HIV in order to craft appropriate advocacy and policy strategies and speed the pace of research.
- IAS2013: BIT225 reduces HIV reservoirs
- IAS2013: American HIV treatment Guidelines get it right
- IAS2013: Very long acting treatment (1 dose per month) is moderately well tolerated
- IAS2013: Study offers more details on people who control HIV after stopping ARVs
- IAS2013: Potential HIV remission in two transplant recipients
Send EmailAlan McCordDirector of Education
Alan provides information to individuals and service providers on HIV health and wellness, including overseeing the HIV Health InfoLine, the HELP-4-HEP hepatitis C support line, and Project Inform’s range of educational publications.
- Project Inform launches new educational videos on PrEP
- Certain people with HIV may be at higher risk for cryptococcal disease
- FDA approves the first genotype test for hepatitis C
- New results suggest exercise may reduce neuro-cognitive impairment in HIV
- Slightly higher risk of AIDS-related conditions seen at 500–750 CD4s
Send EmailAndrew ReynoldsHepatitis C Education Manager
Andrew works on a range of HCV-related issues including writing fact sheets and health booklets, managing awareness and testing campaigns and working on viral hepatitis policy and advocacy issues.
- Project Inform holds annual Think Tank on scaling up risk-based hepatitis C screening
- Project Inform applauds changes to final recommendations on hepatitis C testing
- FDA grants priority review for sofosbuvir, new drug for curing hepatitis C
- Three major events promote month of May as Hepatitis Awareness Month
- All-oral regimen for hep C designated “breakthrough therapy” by FDA